🏛️ Medicare price negotiation compresses pharma pricing power and biotech returns
The IRA's prescription-drug price cap and Medicare negotiation authority — the second-largest line in the bill — permanently lowers the price the largest buyer in the market pays, cutting pharma revenue, the R&D it funds, and the returns available to biotech investors. Sacks calls it price fixing with a downstream hit to new-drug funding; Friedberg thinks the drug-count effect is small but concedes biotech IRRs fall from ~48% to ~28%.
⚖ Why this verdict
fully deterministic — evaluate.py replays this from daily closes; nothing below is editable or hand-set
- Window: 2022-08-20 → 2023-08-20 — first mention + 12-month horizon, then the window locks.
- The call: ▼ SHORT XBI (primary play). XBI fell 9.8% over the window → direction-adjusted R = +9.8% (the call made money).
- Benchmark: holding SPY over the same window returned +7.3%
→ α = +9.8 − (+7.3) = +2.5%
— what this call made or lost against just owning the index. This is the number the verdict uses.
Stock-selection read: +17.1% — did XBI move the predicted way relative to the market. The two only differ on a SHORT: this call was right about direction relative to the index but still cost money versus holding it.
- Rule fired:
· HIT — R ≥ +10% AND α ≥ +5▶ PARTIAL — R ≥ +5% OR α ≥ 0· MISS — everything else
- Credit: supporters of a PARTIAL earn 0.5 each, opposers the inverse — this feeds the scoreboard weights. supported: Chamath, Friedberg, Sacks | proxy-sensitive: IBB→MISS (-0.1%); PFE→HIT (+22.0%)
Conviction timeline
bands: green ≥ 65 · watch ≥ 45 · ember ≥ 15
Plays vs SPY · % since first mention (2022-08-20)
Plays
| expression | symbol | kind | relevance | rationale |
|---|---|---|---|---|
| ▼ SHORT | XBI | etf | PRIMARY | equal-weight biotech — where reduced R&D funding and compressed returns show up first |
| ▼ SHORT | IBB | etf | adjacent | large-cap biotech, more exposed to the negotiated-price list itself |
| ▼ SHORT | PFE | stock | adjacent | big-pharma proxy for the pricing-power leg of the thesis |
Mention log
“And so I'm hopeful that this will actually provide a more effective market force in allowing the biggest customer in the market to negotiate prices and that the VCs, instead of making 48% IRR, they'll ultimately make 28% IRR on the investments that they're making in biotech startups.”
“Well, I mean, you're saying that these drug companies are going to make a lot less money. Well, obviously, that's going to have a downstream impact in the willingness to fund new drugs, new investment, new R&D.”
“And, you know, they're in the midst right now of completing a massive facility. I think it's in Virginia where they'll be able to make as much insulin as is needed for the entirety of America for no more than 35 bucks a dose.”
Who built this conviction
each voice's total force on the score — supports and opposes from every mention, weighted exactly as the replay applied them · share = % of all mention-driven movement
⏳ decay drained -49.7 over the idea's life — that's time passing, attributed to no one
Score events
| episode | kind | Δ | after | note |
|---|---|---|---|---|
| E92 2022-08-20 | init | +33.8 | 33.8 | E92 born by Sacks (explicit_prediction x2) [w=0.97] |
| E92 2022-08-20 | reinforce | +12.5 | 46.3 | E92 Friedberg support x2 (new voice) [w=0.84] |
| E92 2022-08-20 | reinforce | +12.3 | 58.6 | E92 Chamath support x2 (new voice) [w=1.02] |
| E93 2022-08-26 | decay | -2.3 | 56.3 | E93 silent |
| E94 2022-09-01 | decay | -2.3 | 54.0 | E94 silent |
| E95 2022-09-10 | decay | -2.2 | 51.9 | E95 silent |
| E96 2022-09-17 | decay | -2.1 | 49.8 | E96 silent |
| E97 2022-09-23 | decay | -2.0 | 47.8 | E97 silent |
| E98 2022-10-01 | decay | -1.9 | 45.9 | E98 silent |
| E99 2022-10-07 | decay | -1.8 | 44.1 | E99 silent |
| E100 2022-10-14 | decay | -1.8 | 42.3 | E100 silent |
| E101 2022-10-22 | decay | -1.7 | 40.6 | E101 silent |
| E102 2022-10-29 | decay | -1.6 | 39.0 | E102 silent |
| E103 2022-11-05 | decay | -1.6 | 37.4 | E103 silent |
| E105 2022-11-19 | decay | -1.5 | 35.9 | E105 silent |
| E106 2022-12-03 | decay | -1.4 | 34.5 | E106 silent |
| E107 2022-12-10 | decay | -1.4 | 33.1 | E107 silent |
| E108 2022-12-16 | decay | -1.3 | 31.8 | E108 silent |
| E109 2022-12-24 | decay | -1.3 | 30.5 | E109 silent |
| E110 2023-01-06 | decay | -1.2 | 29.3 | E110 silent |
| E111 2023-01-13 | decay | -1.2 | 28.1 | E111 silent |
| E112 2023-01-20 | decay | -1.1 | 27.0 | E112 silent |
| E113 2023-01-27 | decay | -1.1 | 25.9 | E113 silent |
| E114 2023-02-04 | decay | -1.0 | 24.9 | E114 silent |
| E115 2023-02-11 | decay | -1.0 | 23.9 | E115 silent |
| E116 2023-02-17 | decay | -1.0 | 22.9 | E116 silent |
| E118 2023-03-03 | decay | -0.9 | 22.0 | E118 silent |
| E119 2023-03-11 | decay | -0.9 | 21.1 | E119 silent |
| E120 2023-03-17 | decay | -0.8 | 20.3 | E120 silent |
| E121 2023-03-24 | decay | -0.8 | 19.5 | E121 silent |
| E122 2023-03-31 | decay | -0.8 | 18.7 | E122 silent |
| E123 2023-04-07 | decay | -0.7 | 17.9 | E123 silent |
| E124 2023-04-14 | decay | -0.7 | 17.2 | E124 silent |
| E125 2023-04-21 | decay | -0.7 | 16.5 | E125 silent |
| E126 2023-04-28 | decay | -0.7 | 15.9 | E126 silent |
| E128 2023-05-12 | decay | -0.6 | 15.2 | E128 silent |
| E129 2023-05-19 | decay | -0.6 | 14.6 | E129 silent |
| E130 2023-05-26 | decay | -0.6 | 14.0 | E130 silent |
| E131 2023-06-02 | decay | -0.6 | 13.5 | E131 silent |
| E132 2023-06-10 | decay | -0.5 | 12.9 | E132 silent |
| E133 2023-06-16 | decay | -0.5 | 12.4 | E133 silent |
| E134 2023-06-24 | decay | -0.5 | 11.9 | E134 silent |
| E135 2023-07-01 | decay | -0.5 | 11.5 | E135 silent |
| E136 2023-07-09 | decay | -0.5 | 11.0 | E136 silent |
| E137 2023-07-14 | decay | -0.4 | 10.6 | E137 silent |
| E139 2023-07-27 | decay | -0.4 | 10.1 | E139 silent |
| E140 2023-08-04 | decay | -0.4 | 9.7 | E140 silent |
| E141 2023-08-11 | decay | -0.4 | 9.3 | E141 silent |
| E142 2023-08-18 | decay | -0.4 | 9.0 | E142 silent |